Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. 2016

Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
Public Health England, Salisbury.

The highly glycosylated glycoprotein spike of Ebola virus (EBOV-GP1,2) is the primary target of the humoral host response. Recombinant EBOV-GP ectodomain (EBOV-GP1,2ecto) expressed in mammalian cells was used to immunize sheep and elicited a robust immune response and produced high titers of high avidity polyclonal antibodies. Investigation of the neutralizing activity of the ovine antisera in vitro revealed that it neutralized EBOV. A pool of intact ovine immunoglobulin G, herein termed EBOTAb, was prepared from the antisera and used for an in vivo guinea pig study. When EBOTAb was delivered 6 hours after challenge, all animals survived without experiencing fever or other clinical manifestations. In a second series of guinea pig studies, the administration of EBOTAb dosing was delayed for 48 or 72 hours after challenge, resulting in 100% and 75% survival, respectively. These studies illustrate the usefulness of EBOTAb in protecting against EBOV-induced disease.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
November 2018, The Journal of infectious diseases,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
October 2019, Nature medicine,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
July 2022, Antiviral research,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
January 2015, Infectious diseases of poverty,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
April 2021, The American journal of nursing,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
July 2003, Journal of virology,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
March 2017, Immunotherapy,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
June 2022, Current opinion in virology,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
September 2016, Nature reviews. Drug discovery,
Stuart David Dowall, and Jo Callan, and Antra Zeltina, and Ibrahim Al-Abdulla, and Thomas Strecker, and Sarah K Fehling, and Verena Krähling, and Andrew Bosworth, and Emma Rayner, and Irene Taylor, and Sue Charlton, and John Landon, and Ian Cameron, and Roger Hewson, and Abdulsalami Nasidi, and Thomas A Bowden, and Miles W Carroll
July 2016, Scientific reports,
Copied contents to your clipboard!